PIRS - Pieris Pharmaceuticals GAAP EPS of -$0.45 beats by $0.02 revenue of $25.9M misses by $0.67M
2023-03-29 07:05:41 ET
- Pieris Pharmaceuticals press release ( NASDAQ: PIRS ): FY GAAP EPS of -$0.45 beats by $0.02 .
- Revenue of $25.9M (-17.5% Y/Y) misses by $0.67M .
- Cash, cash equivalents, and investments totaled $59.2 million for the year ended December 31, 2022, compared to a cash and cash equivalents balance of $117.8 million for the year ended December 31, 2021.
- The Company believes operations are sufficiently funded for more than the next 12 months.
For further details see:
Pieris Pharmaceuticals GAAP EPS of -$0.45 beats by $0.02, revenue of $25.9M misses by $0.67M